Y. POURSHOJAEI et al.: Ultrasound-assisted and Efficient Knoevenagel Condensation Reaction …
23
Methyl (E)-2-cyano-3-(4-(piperidin-1-yl)phenyl)acrylate (3o):
m.p. 96–99 °C; IR (KBr) (νmax / cm–1): 3022, 3002, 2936,
2851, 2215, 1714, 1612, 1573, 1523, 1416, 1361, 1281,
1226, 1182, 1131, 1092, 1015, 808, 759, 578, 496. 1H NMR
(300 MHz, CDCl3) δ / ppm: 7.98 (1H, s, CHvinylic), 7.83 (2H, d,
J = 9 Hz, CHAr), 6.77 (2H, d, J = 9 Hz, CHAr), 3.80 (3H, s, OCH3),
3.37 (4H, brs, CH2NCH2), 1.60 (6H, brs, 3 × CH2). 13CNMR (75
MHz, CDCl3) δ / ppm: 164.7, 154.4, 154.0, 134.2, 120.0,
117.4, 113.2, 94.0, 52.8, 48.1, 25.3, 24.3. Anal. Calcd. w / %
for C16H18N2O2 (270.33): C, 71.09; H, 6.71; N, 10.36; Found:
C, 71.15; H, 6.68; N, 10.33.
CDCl3) δ / ppm: 8.21 (1H, s, CHvinylic), 8.03 (2H, d, J = 9 Hz,
CHAr), 7.41 (4H, brs, CHAr), 7.07 (2H, d, J = 9 Hz, CHAr), 5.15
(2H, s, OCH2), 3.95 (3H, s, OCH3). 13CNMR (75 MHz, CDCl3) δ
/ ppm: 163.5, 162.6, 154.5, 134.3, 134.2, 133.7, 128.9,
128.8, 124.7, 116.1, 115.5, 99.2, 69.5, 53.2. Anal. Calcd.
w / % for C18H14ClNO3 (327.76): C, 65.96; H, 4.31; N, 4.27;
Found: C, 65.91; H, 4.25; N, 4.36.
Methyl (E)-3-(3-((4-chlorobenzyl)oxy)phenyl)-2-cyanoacrylate
(3t): m.p. 83–86 °C; IR (KBr) (νmax / cm–1): 2955, 2918, 2223,
1730, 1607, 1576, 1492, 1445, 1267, 1247, 1180, 1095, 804,
679. 1HNMR (300 MHZ, CDCl3) δ / ppm: 8.25 (1H, s, CHvinylic),
7.71 (1H, s, CHAr), 7.53 (1H, d, J = 9 Hz, CHAr), 7.44 (1H, t, J =
9 Hz, CHAr), 7.41–7.38 (4H, m, CHAr), 7.20 (1H, d, J = 9 Hz,
CHAr), 5.13 (2H, s, OCH2), 3.97 (3H, s, OCH3). 13CNMR (75
MHz, CDCl3) δ / ppm: 162.9, 158.8, 155.1, 134.7, 134.0,
132.6, 130.4, 128.9, 128.8, 124.9, 121.1, 115.5, 115.2,
102.8, 69.4, 53.4. Anal. Calcd. w / % for C18H14ClNO3
(327.76): C, 65.96; H, 4.31; N, 4.27; Found: C, 65.91; H, 4.25;
N, 4.36.
Methyl (E)-2-cyano-3-(4-(2-morpholinoethoxy)phenyl)acrylate
(3p): m.p. 203–207 °C; IR (KBr) (νmax / cm–1): 2957, 2925,
2224, 1726, 1599, 1512, 1434, 1274, 1212, 1185, 1127, 943,
1
838, 526. HNMR (300 MHz, DMSO-d6) δ / ppm: 8.33 (1H,
s, CHvinylic), 8.09 (2H, d, J = 9 Hz, CHAr), 7.20 (2H, d, J = 9 Hz,
CHAr), 4.32 (2H, t, J = 6 Hz, OCH2), 3.86 (3H, s, OCH3), 3.67
(4H, t, J = 6 Hz, CH2OCH2), 2.96 (2H, t, J = 6 Hz, CH2N), 2.71
(2H, brs, CH2N), 2.52 (2H, brs, CH2N). 13CNMR (75 MHz,
DMSO-d6) δ / ppm: 163.3, 163.0, 155.0, 134.0, 124.6, 116.7,
116.0, 98.9, 65.8, 65.5, 56.6, 53.6, 53.5. Anal. Calcd. w / %
for C17H20N2O4 (316.36): C, 64.54; H, 6.37; N, 8.86; Found:
C, 64.49; H, 6.43; N, 8.81.
Ethyl (E)-2-cyano-3-(4-(4-phenylpiperidin-1-yl)phenyl)acrylate
(3x): m.p. 115–116 °C; IR (KBr) (νmax / cm–1): 3021, 2992,
2933, 2208, 1727, 1609, 1563, 1510, 1274, 1226, 1172, 964,
812, 751, 705, 517; 1HNMR (300 MHZ, CDCl3) δ / ppm: 8.10
(s, 1H, CHVinylic), 7.96 (d, 2H, J = 9 Hz, CHAr), 7.36–7.18 (m,
5H, CHPh), 6.89 (d, J = 9 Hz, 2H, CHAr), 4.38 (q, J = 6 Hz, 2H,
OCH2), 3.99 (d, J = 9 Hz, 2H, CHAr), 2.93 (d.t, 2H, 1J = 9 Hz, 2J
= 3 Hz, 2CH), 2.61 (d, J = 6 Hz, 2H, CH2) 1.92–1.86 (m, 1H,
CH), 1.81 (d, J = 12 Hz, 2H, 2CH), 1.41 (t, J = 6 Hz, 3H, CH3),
1.35 (d, J = 3 Hz, 2H, 2CH). 13CNMR (75 MHz, CDCl3) δ / ppm:
164.2, 154.3, 153.9, 139.9, 134.1, 129.1, 128.4, 126.1,
120.3, 117.4, 113.4, 94.9, 81.9, 47.5, 42.9, 38.1. 31.5, 14.3.
Anal. Calcd. w / % for C24H26N2O2: C, 76.98; H, 7.00; N, 7.48;
Found: C, 77.01; H, 7.13; N, 7.51.
Methyl (E)-2-cyano-3-(3-(2-morpholinoethoxy)phenyl)acrylate
(3q): m.p. 180–183 °C; IR (KBr) (νmax / cm–1): 2953, 2923,
2852, 2224, 1734, 1610, 1580, 1437, 1243, 1130, 954, 684,
515. 1HNMR (300 MHz, DMSO-d6) δ / ppm: 8.40 (1H, s,
CHvinylic), 7.69 (1H, d, J = 9 Hz, CHAr), 7.67 (1H, s, CHAr), 7.53
(1H, t, J = 9 Hz, CHAr), 7.28 (1H, d, J = 9 Hz, CHAr), 4.25 (2H,
t, J = 6 Hz, OCH2), 3.88 (3H, s, OCH3), 3.67 (4H, t, J = 3 Hz,
CH2OCH2), 2.94 (2H, t, J = 6 Hz, CH2N), 2.70 (4H, brs,
CH2NCH2). 13CNMR (75 MHz, DMSO-d6) δ / ppm: 162.7,
158.9, 155.5, 133.0, 130.9, 123.7, 120.4, 116.9, 116.0,
103.0, 65.8, 65.2, 56.7, 53.8, 53.5. Anal. Calcd. w / % for
C17H20N2O4 (316.36): C, 64.54; H, 6.37; N, 8.86; Found: C,
64.61; H, 6.39; N, 8.92.
Ethyl (E)-2-cyano-3-(4-(2-morpholinoethoxy)phenyl)acrylate
(3y): m.p. 217–218 °C; IR (KBr) (νmax / cm–1): 3033, 2996,
2938, 2217, 1718, 1588, 1514, 1263, 1185, 940, 834, 517;
1HNMR (300 MHZ, CDCl3) δ / ppm: 8.32 (s, 1H, CHvinylic), 8.09
(d, J = 9 Hz, 2H, CHAr), 7.18 (d, J = 9 Hz, 2H, CHAr), 4.31 (q, J
= 6 Hz, 2H, OCH2), 4.30 (brs, 2H, CH2), 3.66 (brs, 4H, 2CH2),
2.92 (brs, 2H, CH2), 2.68 (brs, 4H, 2CH2), 1.32 (3H, t, J = 6 Hz,
CH3). 13CNMR (75 MHz, CDCl3) δ / ppm: 163.0, 162.8, 154.9,
133.9, 124.6, 116.7, 115.9, 99.2, 65.9, 65.6, 62.6, 56.7, 53.5,
14.5. Anal. Calcd. w / % for C18H22N2O4: C, 65.44; H, 6.71; N,
8.48. Found: C, 65.49; H, 6.68; N, 8.50.
Methyl (E)-3-(4-(4-bromobenzyl)oxy)phenyl)-2-cyanoacrylate
(3r): m.p. 129–132 °C; IR (KBr) (νmax / cm–1): 3027, 2948,
2218, 1724, 1590, 1514, 1434, 1311, 1268, 1214, 1184,
1
1094, 1070, 804, 759, 515. HNMR (300 MHz, CDCl3) δ /
ppm: 8.21 (1H, s, CHvinylic), 8.03 (2H, d, J = 9 Hz, CHAr), 7.57
(2H, d, J = 9 Hz, CHAr), 7.34 (2H, d, J = 9 Hz, CHAr), 7.07 (2H,
d, J = 9 Hz, CHAr), 5.13 (2H, s, OCH2), 3.95 (3H, s, OCH3).
13CNMR (75 MHz, CDCl3) δ / ppm: 163.5, 162.6, 154.5,
134.8, 133.7, 131.9, 129.1, 124.7, 122.3, 116.1, 115.5, 99.2,
69.5, 53.2. Anal. Calcd. w / % for C18H14BrNO3 (372.22): C,
58.08; H, 3.79; N, 3.76; Found: C, 58.11; H, 3.85; N, 3.81.
Ethyl (E)-3-(4-((4-bromobenzyl)oxy)phenyl)-2-cyanoacrylate
(3z): m.p. 140–142 °C; IR (KBr) (νmax / cm–1): 3027, 2948,
2218, 1724, 1590, 1514, 1434, 1381, 1311, 1268, 1214,
1
Methyl (E)-3-(4-((4-chlorobenzyl)oxy)phenyl)-2-cyanoacrylate
(3s): m.p. 142–145 °C; IR (KBr) (νmax / cm–1): 3028, 2951,
2219, 1725, 1589, 1515, 1433, 1387, 1311, 1267, 1214,
1184, 1093, 1005, 831, 759, 563, 514. 1HNMR (300 MHz,
1183, 1093, 1069, 1002, 832, 804, 759, 554, 515. HNMR
(300 MHz, CDCl3) δ / ppm: 8.20 (s, 1H, CHVinylic), 8.03 (d, J =
9 Hz, 2H, CHAr), 7.57 (d, J = 9 Hz, 2H, CHAr), 7.34 (d, J = 9 Hz,
2H, CHAr), 7.08 (d, J = 9 Hz, 2H, CHAr), 5.13 (s, 2H, OCH2),
DOI: 10.5562/cca3261
Croat. Chem. Acta 2018, 91(1), 19–28